Skip to main content

SB 3195 — Hawaii

RELATING TO DRUGS FOR WEIGHT LOSS.

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Requires the Department of Human Services to provide Medicaid and Medicare part D prescription drug program recipients with coverage of glucagon-like peptide-1 (GLP-1) drugs for weight loss. Appropriates funds.

Official abstract, as published by the legislature.

  • SB 3195 is a bill in the Hawaii Senate, 2026 session, introduced January 28, 2026.
  • Sponsored by FEVELLA, AWA, and CHANG, with 2 cosponsors.
  • Current status: introduced.
  • Most recent action (February 2, 2026): Referred to HHS, WAM.
  • Subjects: Appropriation ($), DHS, GLP-1, Medicaid, Medicare, Obesity.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: FEVELLA, AWA, CHANG

Cosponsors (2): Lamosao, McKelvey

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Passed First Reading.
  2. Senate Introduced. Milestone
  3. Senate Referred to HHS, WAM. Latest

Source: Open States. Last checked November 9, 2026. How we keep this accurate ›